MEDIROM Group Reports Q1 2026 Results
TOKYO, May 28, 2026 (GLOBE NEWSWIRE) -- This report presents an overview…
New Research from ATI Advisory Finds I-SNP Enrollment Associated with Better Outcomes for Long-Term Care Residents
ATI Advisory study, supported by AHCA/NCAL, shows correlation between I-SNP enrollment and…
Taurus Meds TRT Claims Evaluated: Powerful Testosterone Replacement Therapy & Taurus Charge ED Medication
Wilmington, DE, May 28, 2026 (GLOBE NEWSWIRE) -- Compounded medications are not…
Cendyn resets hospitality commitment with leadership reorientation
CEO Michael Bennett leads a restructured team built on operator experience, with…
Antaisolar Launches We Cover Solar Roof One-Stop Solution
XIAMEN, China, May 26, 2026 /PRNewswire/ -- On May 20, Antaisolar has launched…
XPPen Debuts Its First-Ever Editing Console, the Pilot Pro, Setting a New Benchmark for Professional Editing Workflows
LOS ANGELES, May 18, 2026 /PRNewswire/ -- As a leading global digital art…
Haier Named the World’s Only IoT Ecosystem Brand in Kantar BrandZ Top 100 for Eight Consecutive Years
QINGDAO, China, May 18, 2026 /PRNewswire/ -- Kantar, a global leader in…
Xinhua Silk Road: Profound world cultural heritage empowers Quanzhou’s transformation into “fashion capital”
BEIJING, May 11, 2026 /PRNewswire/ -- Quanzhou, a historical city in southeast…
Menarini Group Presents New Data from the Phase 1b/2 ELEVATE Study of Elacestrant in Combination with Capivasertib in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
Encouraging safety and preliminary efficacy analysis from the elacestrant and capivasertib Phase 1b…
Haier Biomedical Achieves Double No. 1 Ranking in Euromonitor’s Global Life Science Lab Equipment Report, Caps Three-Phase Global Expansion
QINGDAO, China, May 28, 2026 /PRNewswire/ -- Haier Biomedical (SHA: 688139) has…
